Integra LifeSciences to Host Analyst Forum on November 15, 2010
PLAINSBORO, N.J., Oct. 15, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host the annual Analyst Forum on Monday, November 15, 2010 from 2:00 PM to 5:00 PM ET at the New York Millennium Broadway Hotel in New York City. The meeting will feature presentations by senior management focused on the Company's strategy for future growth and a question and answer session.
The Analyst Forum is open to all analysts and investors. For in person attendance, please RSVP by Monday, November 8, 2010 via email to angela.steinway@integralife.com. Access to the live presentation will be available by dialing 913-227-1352 (access code 9184707) or through a webcast link provided on the Investor Relations homepage on Integra's website at www.integralife.com. Participants by telephone or webcast will not have an interactive option during the question and answer session.
A replay of the Analyst Forum will be accessible following the conclusion of the live event. Access to the replay will be available through November 29, 2010 by dialing 719-457-0820 (access code 9184707) or through the webcast. Additionally, the webcast will be archived on the Investor Relations website.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2009 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
IART-G
CONTACT: Integra LifeSciences Holdings Corp.
John B. Henneman, III, Executive Vice President,
Finance and Administration and Chief Financial Officer
(609) 275-0500
jack.henneman@integralife.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@integralife.com(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.